UAB researchers review how senescent “zombie” cells contribute to skeletal muscle weakness with aging and disease, outlining emerging therapies such as senolytics and senomorphics that could help preserve muscle health and extend health span. go.uab.edu/42e78hN
Really enjoyed this conversation on skeletal muscle, aging, and cellular senescence. Thanks to the Healthspan team for the opportunity to discuss our work and the broader importance of maintaining muscle health across the lifespan!
Muscle mass peaks in your 30s, then declines 3–8% per decade.
By age 80, you've lost roughly 30–50% of the muscle you had at your physiological peak.
In this week's Beyond Healthspan podcast, we talk to Dr. Davis Englund (@DavisEnglund) about what drives that decline at the cellular level—and why senescent cells accumulating in muscle are a primary mechanism.
Senescent cells don't just occupy space. They actively block muscle regeneration through inflammatory signaling that disrupts satellite cell function—the stem cells responsible for muscle repair.
When Englund's group measured blood-based senescence markers in older adults, baseline senescence predicted training response. Higher senescent cell burden meant poorer adaptation to exercise.
The implication: muscle decline during aging isn't just atrophy from disuse. It's an accumulation of damaged cells that sabotage the repair machinery.
Englund explains:
- Why senolytics help muscle repair in old mice but harm it in young ones
- Which cell types in muscle become senescent (fibers vs. satellite cells)
- How mTOR hyperactivity during aging drives sarcopenia instead of growth
- Why exercise itself appears to have senolytic effects
- The difference between clearing senescent cells and suppressing their inflammatory output
- Why tissue-specific senolytics are the next therapeutic frontier
Join us on March 3, 2026 at the UAB Alumni House for The UAB Aging Research Symposium!
For more information, visit: go.uab.edu/agingresearchsymp…
See you there!
Upcoming Postdoc Position! With Chris Nelson’s lab at U of A, we are looking for a fully supported 2-year postdoc to work on muscle gene editing and detection of gene doping in vivo. If interested, email myself and Chris: kmurach@uark.edu and nelsonc@uark.edu #myotwitter
Great to have my friend and colleague @FerdinandvW visit the Englund Lab this week! Fantastic @UABExerciseMed seminar on exercise adaptation in children with cerebral palsy – more exciting work ahead! @ThalackerMercer@UABHeersink
Talented postdoc @KPapanikolaou93 showcasing his early work in the lab examining cellular senescence as a source of skeletal muscle dysfunction at UAB Postdoc Research Day.
@UABHeersink@UABDeptMed@angadyadav2011
Talented postdoc @KPapanikolaou93 showcasing his early work in the lab examining cellular senescence as a source of skeletal muscle dysfunction at UAB Postdoc Research Day.
@UABHeersink@UABDeptMed@angadyadav2011